Pediatric rheumatology

An evidence-based specialist nursing protocol for children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) and its application research

LupusPublished Case report with evidence-based nursing protocol development

Authors' conclusion

This protocol fills the gap in specialized nursing guidelines for pediatric HLAS, standardizes clinical nursing practices, and provides a replicable methodological reference for the development of standardized nursing protocols for other rare pediatric diseases.

Study context

Population
Children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS); one index case admitted March 2025one index case
Methodological detailsmultidisciplinary team, retrospective case analysis, systematic literature search, thromboelastography (TEG)-based quantitative bleeding risk stratification model, Literature search of mainstream Chinese and English databases from establishment to March 2025
  • Multidisciplinary team
  • Retrospective case analysis
  • Systematic literature search
  • TEG-based quantitative bleeding risk stratification model
  • Literature search of mainstream Chinese and English databases from establishment to March 2025

Main finding

As reported in the abstract

  • Protocol enabled early identification of high bleeding risk, avoiding severe bleeding events and nosocomial infections in the index case
  • Standardized health education and targeted psychological intervention significantly improved caregivers' disease cognition and family self-management ability
  • Nurses transformed from passive caregivers to proactive care managers

Observational data: associations, not effects.

Original publication

An evidence-based specialist nursing protocol for children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) and its application research. Lupus. Published 2 July 2026. doi:10.1177/09612033261466744

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.